Lu Liu - research works

This study demonstrates a significant J-shaped nonlinear association between the TyG index and the risk of in-hospital MACE, with an identified inflection point at 9.05.

Notably, patients with a medium TyG level (T2 group) exhibited the highest MACE risk, which was significantly greater than that of patients with a low TyG level (T1 group).

This finding challenges the conventional linear perception that a higher TyG index consistently correlates with greater risk.

This series suggests that chelation therapy may be temporally associated with acute worsening in this specific population, highlighting a potential therapeutic dilemma: the standard treatment for mercury may, in some cases, be associated with exacerbation of the autoimmune process that may be related to its use.

Screening for occult heavy metal exposure may be considered in unexplained AE, and immunotherapy should be initiated promptly if deterioration occurs.

C-index and BRI are strongly and positively associated with multimorbidity.

These simple, non-invasive indices may support community-based risk stratification and help identify individuals who warrant further clinical and nutritional assessment.

The AEN score is a robust prognostic tool linking PCD activity to PCa aggressiveness and immune evasion. EZR emerges as a functional effector and potential therapeutic target acting through Hippo signaling in PCa.